Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 15/3/2021
SIETES contiene 93212 citas

 
 
 1 a 20 de 141 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Tisdale JE, Chung MK, Campbell KB, Hammadah M, Joglar JA, Rajagopalan B, On behalf of the American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke Nursing. Drug-induced arrhythmias. A scientific statement from the American Heart Association. Circulation 2020;142:16 de septiembre. [Ref.ID 103712]
2. Cita con resumen
Buckley NA, Dawson AH, Isbister GK. Serotonin syndrome. BMJ 2014;348:g1626. [Ref.ID 97343]
3. Cita con resumen
Anónimo. Valvulopathies d'origine médicamenteuse. Prescrire 2013;33:668-72. [Ref.ID 96188]
4. Cita con resumen
Montastruc F, Montastruc G, Vigreux P, Bruneval P, Guilbeau-Frugier C, Cron C, Bagheri H, Delisle B, Lapeyre-Mestre M, Pathak A, Montastruc J-L. Valvular heart disease in a patient taking 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'). Br J Clin Pharmacol 2012;74:547-8. [Ref.ID 93709]
5. Cita con resumen
Seetohul LN, Maskell PD, De Paoli G, Pounder DJ. Designer drugs. Deaths associated with new designer drug 5-IT. BMJ 2012;345:22. [Ref.ID 93701]
6. Cita con resumen
Anónimo. Nearly 15,000 ED visits linked to patients being unwittingly drugged. DIA Daily 2011:11 de novembre. [Ref.ID 91606]
7. Cita con resumen
Anónimo. Ecstasy use does not reduce mental ability. BMJ 2011;342:406. [Ref.ID 90226]
8. Cita con resumen
Kuehn BM. Teen marijuana use on the rise. JAMA 2011;305:242. [Ref.ID 90088]
9. Cita con resumen
Reuben A, Koch DG, Lee WM, Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010;52:2065-76. [Ref.ID 89970]
10.Tiene citas relacionadas
Álvarez Vara C. Éxtasis: un viejo éxito inquietante. Rev Clin Esp 2010;210:394-6. [Ref.ID 89055]
12. Cita con resumen
Dyer C. Scientists protest against proposals on advisory group membership. BMJ 2010;340:384. [Ref.ID 87888]
13. Cita con resumen
Gossop M, Hall W. Clashes between the government and its expert advisers. BMJ 2009;339:1095-6. [Ref.ID 87270]
14. Cita con resumen
Blakemore C. Classification of cannabis and ecstasy in the UK. BMJ 2009;338:490-1. [Ref.ID 85381]
15. Cita con resumen
Kmietowicz Z. UK government rejects advice from drugs adviser to downgrade ecstasy. BMJ 2009;338:435. [Ref.ID 85329]
18.Tiene citas relacionadas Cita con resumen
Nutt D, King L, Saulsbury W, Blakemore C. Assessing drug-related harm. Authors' reply. Lancet 2007;369:1857. [Ref.ID 80189]
19.Tiene citas relacionadas Cita con resumen
Murphy PN. Assessing drug-related harm. Lancet 2007;369:1856. [Ref.ID 80187]
20. Cita con resumen
Ellison DH, Berl T. The syndrome of inappropriate antidiuresis. N Engl J Med 2007;356:2064-72. [Ref.ID 80043]
Seleccionar todas
 
 1 a 20 de 141 siguiente >>